Eva Pharma is one of the leading and fastest growing pharmaceutical manufacturers in the MENA region, with a 30%+ CAGR over the past five years. It is a branded generics powerhouse which also operates in OTC and food supplements. Eva Pharma has a portfolio of over 126 products; covering various therapeutic classes including Neurology, Psychiatry, Cardiovascular, Orthopedics, GIT, Pediatrics, Urology and Dermatology. The company has its own sales teams in many countries of the MENA region including Egypt, KSA, UAE, Bahrain, Qatar, Oman, Kuwait, Iraq, Lebanon, Yemen, Kenya, Libya & Ethiopia. Its distinctive state-of-the-art manufacturing facility in Cairo is approved by EMA, SFDA & GCC authorities allowing it to be a contract manufacturer for some of the leading companies in the globe. Eva Pharma is led by a distinctive team of professionals with a forward thinking philosophy, it continues to add local and international manufacturing facilities wherever opportunities arise and is growing strategically to ensure its high quality affordable products are available for all.
Contact
Armanious Group Tower, 9 El Sharekat Street, Opera – Abdeen, Cairo, Egypt
P.O. Box: 1002 & 845
Postal code: 11518
Egypt is at the ‘golden stage’ for investment, claims Boehringer Ingelheim country head Mohamed El-Sahhar, who explains how the company is expanding their organization in Egypt ahead of an expansion…
Pharmed Healthcare is the only Egyptian company to hold a License from the innovator to produce generic sofosbuvir, but faces competition from at least ten different companies in the market. Given…
The Managing Director of MSD Egypt highlights MSD’s unique incentives to further collaborate with the Egyptian medical community and explains how market peculiarities shape product launches in developing countries like…
Dr. Mohamed El Ganayni, Managing Director at UniPharma discusses the challenges in standing out among a crowd of Egyptian pharmaceutical manufacturers, elaborates on his ambitions to become a Top 30…
Empty markets, where strong and growing demand exists but local supply does not, offer the most potential to prospective investors in Egypt, according to Delta Pharma Bio general manager Mohamed…
Deputy Minister of Health for Pharmaceutical Affairs Tarek Salman discusses how pharmaceutical regulation in Egypt is taking a leap forward, with the introduction of new legislation with parallel registration process…
In Egypt’s diverse marketplace, Novo Nordisk is bringing care to patients across the country with a range of products ranging from affordable established insulin to their most recent generation of innovative…
Abbvie has taking a leading role in the Egyptian pharmaceutical industry by bringing their new all-oral hepatitis C treatment to Egypt, the country with the highest prevalence of the disease…
Bayer broke into the top ten multinationals in Egypt this year, after achieving a remarkable 110 percent growth over the last two years. General manager Hatem Safei discusses the developments…
Country manager AbdelAziz Shaheen discusses Pfizer’s current and recent investments in Egypt, which include significant contributions to the continuous education of Egyptian pharmacists and health care professionals. With 54 years history…
“Egypt will become the largest market for pharmaceuticals within the region in the next three years”; Ahsraf Elkhouly, Executive Director the Egyptian Society for Pharmaceutical Research (ESPR), highlights Egypt’s untapped…
“Egypt: the golden gate to Africa” – The head of the export council of medical industries reviews the remaining obstacles on the way to double the value of Egyptian exports…
See our Cookie Privacy Policy Here
